Work

JCO at ASCO Annual Meeting: Neoadjuvant Osimertinib for Resectable EGFR-Mutated NSCLC

Year: 2025

Type: dataset

DOI: 10.1200/jco.25.0602

Authors: Thomas Stinchcombe, Ece Cali

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410942219

Cites:

Cited by:

Related to: 10